x
ServiziMenu principaleHome
You are here: Home > Educational Opportunities > Past events > 2013 > ESOP-ESO Advanced Masterclass in Oncology Pharmacy
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

ESOP-ESO Advanced Masterclass in Oncology Pharmacy

Not eligible for ESCO credits

21.10.2013  -  25.10.2013

Dresden

MASTERCLASS

Pharmacology

Description

Chairs: A. Astier, FR - M. Daouphars, FR - P.H. Honoré, SE/DK - E.E. Korczowska, PL - K. Meier, DE - B.J. Sobkowiak, PL - R. Terkola, AT


INTRODUCTION
The European Society of Oncology Pharmacy holds a three level Masterclass programme:

• Basic Masterclass and
• Intermediate Masterclass (held jointly also on 21-25 October in Dresden, Germany)
• Advanced Masterclass


The first two courses are organised by ESOP (further information available at www.esop.eu), whilst herewith the ESOP-ESO Advanced Masterclass is presented.

The Advanced Masterclass will be mainly based on clinical cases covering the majority of diseases and pharmaceutical cases which can occur in the clinical setting. Some cases will be focused on less common cancer entities such as haematological malignancies, paediatric cancer, cancer of geriatric patients, treatment of patients with organ dysfunctions (renal, liver, cardiac, etc.) and rare cancers.

The hematopoietic stem cell transplant patients shall be also covered. Clinical cases should familiarise the oncology pharmacist to complex situations where pharmaceutical expertise is required to improve the treatment (toxicities and their management,  symptom management, drug interactions of anticancer agents, management of side-effects, etc.), oncological emergencies and patient counseling. Current practice, recent advances and emerging therapies as well as case studies highlighting pertinent issues shall be introduced. Pharmaceutical situation shall also refer to the content of prior levels like problems concerning drug stability, physico-chemical  compatibility and their possible effects on the patient’s therapy.


LEARNING OBJECTIVES 
• To actively participate with the medical team to the initial management of a cancer patient whatever the tumor location, i.e. definition of the best chemotherapy and the appropriate support treatment, especially based on pharmacokinetics, pharmacodynamics and pharmacogenetics considerations
• To furnish to medical team and nurses all relevant information about new anticancer treatments, their administration and side-effects with a specific concern on pharmaceutical problems such as stability issues
• To manage the potential side-effects of the treatment by the definition of an appropriate prevention plan and their follow-up, especially for out-patients receiving oral anticancer therapies
• To propose a relevant educational plan for the patient (and its family), related to its treatment, with particular focus on the prevention of drug/drug and drug/food interactions


MAIN TOPICS 
• Clinical cases covering the majority of the diseases and pharmaceutical cases that can occur in the clinical setting
• The hematopoietic stem cell transplant patient and other complex situations
• Toxicities and symptom management
• Drug interactions of anticancer agents
• Oncological emergencies
• Patient counseling
• Clinical trials
• Research
• Collective prescription process
• Drug and therapeutic committee
• Pharmaco-economics

General information

ORGANISING SECRETARIAT
ESOP Membership Service
c/o DGOP e.V.
Cuxhavener Straße 36, 21149 Hamburg, Germany
Ph +49 40 790 3356 - Fax:  +49 40 791 43601
membershipservice@esop.li
www.esop.eu

Programme


21 October

08:45

Welcome Coffee

09:00

Radiotherapy - Principles and Use in Oncology
W. Wagner

 09:45

Radiotherapy - Principles and Use in Oncology
W. Wagner

 10:30  

Treatment of Oncology Patients with Organ Dysfunctions: Renal Impairment
H.-P. Lipp

11:30

Treatment of Oncology Patients with Organ Dysfunctions: Liver Impairment
H.-P. Lipp

12:30

Lunch

13:30

Clinical Presentation, Diagnosis and Treatment: Lung Cancer
E. Laack

14:30

Clinical Presentation, Diagnosis and Treatment: Lung Cancer
E. Laack

15:30

Coffee Break

15:45

Cancer Biology - Etiology of Cancer
J. Stanislawiak-Rudowicz
 16:30 Epidemiology of Cancer & Factors influencing Cancer Development
J. Stanislawiak-Rudowicz
 17:15 Tumor Classification, TNM-System, Grading and Staging
M. Dietel
 18:00 Personalized Oncology and Predictive molecular diagnostic
M. Dietel

 

22 October

 08:30  

 Clinical Presentation, Diagnosis and Treatment: Esophageal and Esophagogastric Junction Cancer
G. Wiedemann

 09:15

Clinical Presentation, Diagnosis and Treatment: Esophageal and Esophagogastric Junction Cancer
G. Wiedemann

10:00

Coffee Break

10:15

Clinical Presentation, Diagnosis and Treatment: Gastric Cancer
G. Wiedemann

11:15

Clinical Presentation, Diagnosis and Treatment: Colon Rectal Cancer
G. Wiedemann

12:00

Lunch

13:00

G. Wiedemann
Clinical Presentation, Diagnosis and Treatment: Colon Rectal Cancer

13:45

P. Mohr
Clinical Presentation, Diagnosis and Treatment: Melanoma

14:45

Coffee Break

15:00

Clinical Presentation, Diagnosis and Treatment: Non-Melanoma Skin Cancers
P. Mohr

16:00

Clinical Presentation, Diagnosis and Treatment: Basal and Squamos Cell Skin Cancers
P. Mohr

 

23 October

 08:30  

Clinical Presentation, Diagnosis and Treatment: ALL, AML and CML
B. Wörmann

 09:30

Clinical Presentation, Diagnosis and Treatment: ALL, AML and CML
B. Wörmann

 10:30

Coffee Break

 10:45

Clinical Presentation, Diagnosis and Treatment: Hodgkin and Non-Hodgkin Lymphoma
B. Wörmann

 11:45

Clinical Presentation, Diagnosis and Treatment: Breast Cancer
K. Possinger

 12:45

Lunch

 13:45Clinical Presentation, Diagnosis and Treatment: Breast Cancer
K. Possinger
 14:45 Clinical Presentation, Diagnosis and Treatment: Head and Neck Cancer
S. Koscielny

 15:30

Clinical Presentation, Diagnosis and Treatment: Head and Neck Cancer
S. Koscielny

 16:15

Coffee Break
 16:30 Clinical Presentation, Diagnosis and Treatment: Soft Tissue Sarcoma
P. Reichardt

 17:30

Clinical Presentation, Diagnosis and Treatment: Soft Tissue Sarcoma
P. Reichardt

 

24 October

 08:30  

Side Effects of Anticancer Drugs
P. Hartvig-Honoré
B.J. Sobkowiak

 09:30

Side Effects of Anticancer Drugs
P. Hartvig-Honoré

 10:30

Interactions of Anticancer Drugs
P. Hartvig-Honoré

 11:30

Lunch

 12:30

Clinical Presentation, Diagnosis and Treatment: Ovarian Cancer
L Wölber

 13:30

Clinical Presentation, Diagnosis and Treatment: Cervical Cancer
L Wölber

 14:30

Coffee Break

 14:45

Clinical Presentation, Diagnosis and Treatment: Prostate and Bladder Cancer
M. Fröhner

 15:45

Clinical Presentation, Diagnosis and Treatment: Penile, Testicular and Kidney Cancer
M. Fröhner

 16:45

Coffee Break

 17:00

Treatment of Pediatric Oncology Patients
P. Hartvig-Honoré

 17:45

Treatment of Geriatric Oncology Patients
P. Hartvig-Honoré

 

25 March

08:30   

Multiprofessional Cases
M. Höckel

 09:30

M. Höckel
Multiprofessional Cases

 10:30

Coffee Break

 10:45

M. Höckel
Multiprofessional Cases

 11:45

M. Höckel
Multiprofessional Cases

 12:45

Lunch

 13:45

M. Höckel
Multiprofessional Cases

 14:30

M. Höckel
Multiprofessional Cases

 15:30

Coffee Break

 15:45

Interactive session: Test and Masterclass Evaluation Questionaire & Farewell